We've spent a lot of time discussing Steve's big stock market calls of late… And for good reason… He has been on an absolute tear. Across his three publications – True Wealth, True Wealth Systems, and True Wealth China Opportunities – readers are currently up double digits or better on most of his broad market recommendations in the U.S., Europe, China, and Japan, among others. But make no mistake… Steve has continued to find big, contrarian opportunities for his subscribers across the investment world. For example, in early 2016, Steve alerted subscribers to a huge opportunity in an area of the market most investors had left for dead: the resource sector. At the time, most commodities were in a brutal bear market. Prices had plunged for nearly five straight years… Most resource stocks had lost 75% of their value or more.
Hot Value Stocks To Buy For 2018: B2Gold Corp(BTG)
- [By Peter Graham]
The following mining companies are active in Burkina Faso:
Semafo Inc (TSE: SMF; OTCMKTS: SEMFF).SEMAFO operates the Mana Mine in Burkina Faso, which includes the high-grade satellite deposit of Siou, and is targeting production start-up of the Boungou Mine in the second half of 2018. SEMAFO’s strategic focus is to maximize shareholder value by effectively managing its existing assets as well as pursuing organic and strategic growth opportunities. SEMAFOs Mana Mine is located 260 kilometers southwest of the capital Ouagadougou. The third-largest mine in the country, it has produced some 1.6 million ounces since its first gold pour in 2008. Since then,the Company hasexpanded the plant four times to a current processing rate of over 7,200 tonnes per day. IAMGOLD Corp (NYSE: IAG). Iamgold has four operating gold mines on three continents with asolid base of strategic assets in North and South America and West Africa that is complemented by development and exploration projects with continued assessment of accretive acquisition opportunities. Iamgold is said to be thelargest private employer in Burkina Faso andhas a high level of exposure in the region with two operating mines in Mali and a mine in northern Burkina Faso near the Mali border. Roxgold Inc (TSE: ROXG; OTCMKTS: ROGFF). Roxgold is a gold mining company with its key asset, the high grade Yaramoko Gold Mine, located in the Hound茅 greenstone region of Burkina Faso, West Africa. The Company declared commercial production on October 1, 2016. The Yaramoko permit covers approximately 196km2 in the Province of Bal茅 in southwestern Burkina Faso. The property is located approximately 200 kilometres southwest from the capital city of Ouagadougou. Yaramoko lies directly south of, and is contiguous to, the SEMAFO Inc property hosting its flagship Mana Gold Mine and lies within the Hounde greenstone belt. Endeavour Mining Corp (TSE: EDV; OTCMKTS: EDVMF). Endeavour is ideally positioned as the majo
- [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
- [By Monica Gerson]
B2Gold Corp (NYSE: BTG) is estimated to post its quarterly earnings at $0.00 per share on revenue of $135.84 million.
Astro-Med, Inc. (NASDAQ: ALOT) is projected to post its quarterly earnings at $0.21 per share on revenue of $25.50 million.
Hot Value Stocks To Buy For 2018: Nature's Sunshine Products, Inc.(NATR)
- [By Lisa Levin]
Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).
Hot Value Stocks To Buy For 2018: Jazz Pharmaceuticals Inc.(JAZZ)
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Jim Robertson]
The earnings report summarized the following recent milestones:
The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.
Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.
- [By Ben Levisohn]
Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.
CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.
- [By Teresa Rivas]
Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.
As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.
Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:
While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.
Jazz shares are up 8.9% to $153.2o at recent check.
- [By Benzinga News Desk]
On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link
March 2017 US Challenger layoffs report 43,310 vs 36,975
Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
Data on money supply for the recent week will be released at 4:30 p.m. ET.
Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral
This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email email@example.com.
- [By Keith Speights]
In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.